Use of 5-[76Br]bromo-2′-fluoro-2′-deoxyuridine as a ligand for tumour proliferation: Validation in an animal tumour model

European Journal of Nuclear Medicine

Volumn 29, Issue 1, 2002, Pages 19-27

  Borbath, Ivan ^a,c   Grégoire, Vincent ^a,c   Bergström, Mats ^b,c   Laryea, Daniel ^b,c   Långström, Bengt ^b,c   Pauwels, S Stanislas ^a,c  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UPPSALA UNIVERSITY   (Sweden)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Animal model; Bromodeoxyuridine; PET; Thymidine; Tumour proliferation

Indexed keywords

2 THYMIDINE C 14; 5 BROMO 2' FLUORO 2' DEOXYURIDINE BR 76; BROXURIDINE; CIMETIDINE; GEMCITABINE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE MODEL; DNA SYNTHESIS; DRUG BIOAVAILABILITY; DRUG ELIMINATION; DRUG UPTAKE; FIBROSARCOMA; FLOW CYTOMETRY; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; SMALL INTESTINE; VALIDATION PROCESS;

ANIMALS; AUTORADIOGRAPHY; BROMODEOXYURIDINE; CARBON RADIOISOTOPES; CELL DIVISION; CIMETIDINE; DEOXYCYTIDINE; DNA, NEOPLASM; FIBROSARCOMA; FLOW CYTOMETRY; FLOXURIDINE; GAMMA CAMERAS; MICE; MICE, INBRED C3H; RADIOPHARMACEUTICALS; SCINTILLATION COUNTING; THYMIDINE;

EID: 0036166616     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-001-0689-x     Document Type: Article

References (45)

1. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication
2. Immunohistochemical demonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in human brain tumor tissues
3. 11C)thymidine
4. Short-term thymidine uptake in normal and neoplastic tissues: Studies for PET
5. In vivo measurements of carbon-11 thymidine uptake in non-Hodgkin's lymphoma using positron emission tomography
6. Utilization of labeled thymidine in DNA synthesis: Studies for PET
7. 11C]thymidine
8. 11C-thymidine activity in human head and neck tumours using positron emission tomography (PET)
9. 11C]thymidine for measurement of cell proliferation in fast dividing tissues
10. Brain tumour imaging with PET and 2-(carbon-11)thymidine
11. Iodine-123-iododeoxyuridine: A potential indicator of tumour response to treatment
12. 123I]-iodo-3′-deoxy-beta-D-arabinofuranosyl) uracil
13. Imaging of brain tumor proliferative activity with iodine-131-iododeoxyuridine
14. Contribution of labeled carbon dioxide to PET imaging of carbon-11-labeled compounds
15. Analysis of 2-[C-11]-thymidine blood metabolites in PET imaging
16. 11C]thymidine PET imaging studies: Compartmental model and mathematical analysis
17. 11C]thymidine PET imaging studies: Validation studies
18. 2-[C-11]thymidine of malignant brain tumors
19. 76Br]bromodeoxyuridine as a proliferation marker in conjunction with PET - In vitro and animal validation studies
20. 14C]uracils
21. Development of labeled thymidine analogs for imaging tumor proliferation
22. Imaging proliferation in vivo with F-18FLT and positron emission tomography
23. Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3′-fluoro-3′-deoxythymidine
24. 76Br]bromo-fluoro-deoxyuridine and its validation with regard to uptake, DNA incorporation and excretion modulation in rat
25. Action of 2′, 2′-difluorodeoxycytidine on DNA synthesis
26. Immunological resistance to pulmonary metastases in C3Hf/Bu mice bearing syngeneic fibrosarcoma of different sizes
27. The determination of nucleic acids
28. Cell kinetic analysis of mixed populations using three-color fluorescence flow cytometry
29. Evaluation of flow cytometric methods for determining population potential doubling times using cultured cells
30. Autoradiography using storage phosphor technology
31. In vitro PET evaluations in lung cancer cell lines
32. Renal transepithelial transport of nucleosides
33. Characterization of and the influence of calcium channel blockers on the renal excretion of pyrimidine anticancer agents
34. Interaction of 3′-azido-3′-deoxythymidine with the organic base transporter in a cultured renal epithelium
35. Distribution of kinase and deaminase of 1-beta-D-arabinofuranosylcytosine in tissues of man and mouse
36. Enhancement of tumor radioresponse in vivo by gemcitabine
37. Kinetics of mouse jejunum radiosensitization by 2′,2′-difluorodeoxycytidine (gemcitabine) and its relationship with pharmacodynamics of DNA synthesis, inhibition and cell cycle redistribution in crypt cells
38. Maximizing therapeutic gain with gemcitabine and fractionated radiation
39. Pharmacokinetics of oral and intravenous bromide in normal volunteers
40. Extracellular water measurements: Organ tracer kinetics of bromide and sucrose in rats and man
41. Differential incorporation of ara-C, gemcitabine, and fludarabine into replicating cells and repairing DNA in proliferating human leukemia cells
42. The fate of 5-bromodeoxyuridine, 5-bromodeoxycytidine, and 5-iododeoxycytidine in man
43. Defective transport of thymidine by cultured cells resistant to 5-bromodeoxyuridine
44. Membrane transport and the antineoplastic action of nucleoside analogues
45. Thymidine metabolism and cells kinetics